source
- Garijo's plan to revamp Sanofi: an R&D cleanup, more M&A and a China pushThree months into her role as CEO at Sanofi, Belén Garijo gave some insight on how she plans to boost the French company’s mid- to long-term growth in the face of a looming patent cliff ...Endpoints · 2h ago↗ source
- Pfizer's Phase 3 win for Litfulo; Braveheart, Attovia eye IPOs of $275M, $182MPfizer reports Phase 3 wins for Litfulo: The drug succeeded in two trials for active and stable nonsegmental vitiligo, an autoimmune condition that causes skin to progressively lose its color. One ...Endpoints · 2h ago↗ source
- AtaiBeckley attracted co-development and royalty offers before $2.8B Lilly dealMore details have emerged about how the industry’s largest psychedelic biotech buyout came to fruition. In an SEC filing on Thursday morning, AtaiBeckley disclosed some of the play-by-play from its